Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Nicholas Antos MD

Nicholas Antos MD profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Pulmonary

Clinical Expertise

  • Asthma
  • Cystic Fibrosis
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Neonatal Screening
  • Leadership Positions

  • Director, Pediatric Cystic Fibrosis Program
  • Medical Director, SE Wisconsin School-based Asthma Management Program
  • Director, Cystic Fibrosis Center
  • Publications (14)

  • Defining and identifying early-onset lung disease in cystic fibrosis with cumulative clinical characteristics. (Huang L, Lai HJ, Antos N, Rock MJ, Asfour F, Howenstine M, Gaffin JM, Farrell PM) Pediatr Pulmonol 2022 Oct;57(10):2363-2373 PMID: 35712759 PMCID: PMC9489630 SCOPUS ID: 2-s2.0-85132588336 06/18/2022    
  • Cystic fibrosis learning network telehealth innovation lab during the COVID-19 pandemic: a success QI story for interdisciplinary care and agenda setting. (Albon D, Thomas L, Hoberg L, Stamper S, Somerville L, Varghese P, Balasa E, Roman M, Britto MT, Miner M, Gehring E, Gammon C, Amin RS, Seid M, Powers M, CF Learning Network telehealth iLab working group) BMJ Open Qual 2022 May;11(2) PMID: 35589277 PMCID: PMC9121114 SCOPUS ID: 2-s2.0-85130313310 05/20/2022    
  • Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial. (Nichols DP, Singh PK, Baines A, Caverly LJ, Chmiel JF, GIbson RL, Lascano J, Morgan SJ, Retsch-Bogart G, Saiman L, Sadeghi H, Billings JL, Heltshe SL, Kirby S, Kong A, Nick JA, Mayer-Hamblett N, TEACH Study Group) Thorax 2022 Jun;77(6):581-588 PMID: 34706982 PMCID: PMC9043040 SCOPUS ID: 2-s2.0-85125627383 10/29/2021       2 Citations
  • Cystic fibrosis year in review 2020: Section 2 pulmonary disease, infections, and inflammation. (Antos NJ, Savant AP) Pediatr Pulmonol 2022 Feb;57(2):347-360 PMID: 34033706 SCOPUS ID: 2-s2.0-85106317899 05/26/2021       2 Citations
  • Quality Improvement Approach to Reducing Admission Hypothermia Among Preterm and Term Infants. (Sprecher A, Malin K, Finley D, Lembke P, Keller S, Grippe A, Hornung G, Antos N, Uhing M) Hosp Pediatr 2021 Mar;11(3):270-276 PMID: 33627479 02/26/2021    
  • Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study. (Flume PA, Biner RF, Downey DG, Brown C, Jain M, Fischer R, De Boeck K, Sawicki GS, Chang P, Paz-Diaz H, Rubin JL, Yang Y, Hu X, Pasta DJ, Millar SJ, Campbell D, Wang X, Ahluwalia N, Owen CA, Wainwright CE, VX14-661-110 study group) Lancet Respir Med 2021 Jul;9(7):733-746 PMID: 33581080 SCOPUS ID: 2-s2.0-85101679537 02/14/2021       21 Citations
  • Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients. (Moheet A, Beisang D, Zhang L, Sagel SD, VanDalfsen JM, Heltshe SL, Frederick C, Mann M, Antos N, Billings J, Rowe SM, Moran A, PROSPECT Investigators of the Cystic Fibrosis Foundation Therapeutics Development Network) J Cyst Fibros 2021 Mar;20(2):333-338 PMID: 32917547 PMCID: PMC7937760 SCOPUS ID: 2-s2.0-85090490297 09/13/2020       17 Citations
  • Lactation Consultation Sustains Breast Milk Intake in Infants With Cystic Fibrosis. (Miller T, Antos NJ, Brock LA, Wade T, Goday PS) J Pediatr Gastroenterol Nutr 2019 Sep;69(3):358-362 PMID: 31181018 SCOPUS ID: 2-s2.0-85070818417 06/11/2019       3 Citations
  • Oral health of cystic fibrosis patients at a north american center: A pilot study. (Abu-Zahra R, Antos NJ, Kump T, Angelopoulou MV) Med Oral Patol Oral Cir Bucal 2019 May 01;24(3):e379-e384 PMID: 31011138 PMCID: PMC6530948 SCOPUS ID: 2-s2.0-85065512008 04/24/2019       6 Citations
  • Building school health partnerships to improve pediatric asthma care: the School-based Asthma Management Program. (Kakumanu S, Antos N, Szefler SJ, Lemanske RF Jr) Curr Opin Allergy Clin Immunol 2017 Apr;17(2):160-166 PMID: 28177950 SCOPUS ID: 2-s2.0-85011840277 02/09/2017       14 Citations
  • Creation and implementation of SAMPRO™: A school-based asthma management program. (Lemanske RF Jr, Kakumanu S, Shanovich K, Antos N, Cloutier MM, Mazyck D, Phipatanakul W, Schantz S, Szefler S, Vandlik R, Williams P) J Allergy Clin Immunol 2016 Sep;138(3):711-723 PMID: 27596707 PMCID: PMC5085063 SCOPUS ID: 2-s2.0-84995460912 09/07/2016       65 Citations
  • Improving inpatient cystic fibrosis pulmonary exacerbation care: two success stories. (Antos NJ, Quintero DR, Walsh-Kelly CM, Noe JE, Schechter MS) BMJ Qual Saf 2014 Apr;23 Suppl 1:i33-i41 PMID: 24608549 SCOPUS ID: 2-s2.0-84896535767 03/13/2014       9 Citations
  • Implementing Inpatient Cystic Fibrosis Related Diabetes Screening: Successes and a Resultant Epidemic. (Antos, Nicholas J; Miller, T; Walsh-Kelly, C; Noe, J; Quintero, D.) Pediatric Pulmonology [Abstract] Vol 48, Issue S36, Oct 2013: A496 10/01/2013    
  • Barriers To Initial Administration Of Airway Clearance Therapy In Pediatric Cystic Fibrosis Hospitalizations (Antos, Nicholas J; Walsh-Kelly, CD; Quintero, DR) Am J Respir Crit Care Med. [Abstract]. May 2013. 187: A3887 05/01/2013    
  • Last update: 09/06/2022